U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680244) titled '(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000' on June 17.
Brief Summary: This study will measure how well PathFinder 1.0 detects retinal abnormalities on macular cube OCT B-scans by assessing its sensitivity and specificity.
Study Start Date: May 23, 2025
Study Type: INTERVENTIONAL
Condition:
Epiretinal Membrane
Dry Age Related Macular Degeneration
Macular Abnormalities
Retina Disease
Vitreoretinal Abnormality
Intraretinal Hyporeflective Space
Subretinal Hyporeflective Space
IS/OS (Ellipsoid Zone) Disruption
Retinal Pigment Epithelium (RPE) Elevation
Retinal Pigment Epithelium ...